Government officials are preparing to link Covid vaccines to a number of fatalities, impacting vaccine developers’ reputations. BioNTech’s share price fell 7% after reports of 25 children’s deaths linked to vaccines. CDC emphasizes investigations needed for such claims. Officials plan to present findings to CDC advisory panel next week.

BioNTech, a co-developer of a top Covid vaccine, could suffer reputation damage if linked to harmful products. Consider other stock options recommended by analysts for potential high returns. Stock Advisor has a history of outperforming the S&P 500 significantly. Join for the latest top 10 list and investment opportunities.

Read more at Yahoo Finance: Why BioNTech Stock Sank by More Than 7% Today